Nathan Rice
Stock Analyst at Piper Sandler
(4.23)
# 645
Out of 4,479 analysts
29
Total ratings
58.33%
Success rate
14.1%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Reiterates: Overweight | $59 → $56 | $41.13 | +36.15% | 4 | May 17, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $57.52 | +28.65% | 2 | May 2, 2024 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $39 → $38 | $32.74 | +16.07% | 2 | Apr 29, 2024 | |
| BFC Bank First | Maintains: Neutral | $90 → $87 | $83.60 | +4.07% | 3 | Apr 18, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $239.74 | -6.15% | 9 | Feb 2, 2024 | |
| BY Byline Bancorp | Maintains: Overweight | $27 → $28 | $24.14 | +15.99% | 2 | Jan 30, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $82.50 | +1.82% | 1 | Jan 10, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $14.01 | -35.76% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $477.23 | -8.85% | 2 | Jul 21, 2022 | |
| CI Cigna | Initiates: Neutral | n/a | $325.91 | - | 1 | Dec 14, 2021 | |
| CNC Centene | Initiates: Neutral | n/a | $66.19 | - | 1 | Dec 14, 2021 | |
| OSBC Old Second Bancorp | Initiates: Overweight | n/a | $15.20 | - | 1 | Dec 19, 2019 |
Merchants Bancorp
May 17, 2024
Reiterates: Overweight
Price Target: $59 → $56
Current: $41.13
Upside: +36.15%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $57.52
Upside: +28.65%
First Mid Bancshares
Apr 29, 2024
Maintains: Overweight
Price Target: $39 → $38
Current: $32.74
Upside: +16.07%
Bank First
Apr 18, 2024
Maintains: Neutral
Price Target: $90 → $87
Current: $83.60
Upside: +4.07%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $239.74
Upside: -6.15%
Byline Bancorp
Jan 30, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $24.14
Upside: +15.99%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $82.50
Upside: +1.82%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $14.01
Upside: -35.76%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $477.23
Upside: -8.85%
Cigna
Dec 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $325.91
Upside: -
Centene
Dec 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $66.19
Upside: -
Old Second Bancorp
Dec 19, 2019
Initiates: Overweight
Price Target: n/a
Current: $15.20
Upside: -